Eisai US

Compensation

Full Description

At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you. Eisai is searching for a creative, resourceful, integrative thinker with deep expertise in PET imaging within the neurology space to support clinical and translational research. As the Associate Director, Translational Imaging, Clinical Pharmacology & Translational Medicine, the focus will be primarily on PET imaging to design and plan clinical imaging studies for various neurology clinical programs and interact with imaging vendors, help manage imaging studies, participate in data analysis, modeling and presentation of results to International Project Teams. Stay abreast of the PET neuroimaging field in neuroscience and provide guidance for selection of methods of study design and analysis for PET tracers. Provide a global resource for education, preclinical and translational strategy and application of PET methodology. Interact with key opinion leaders and CROs for successful execution of translational PET imaging studies. Essential Functions Quantitate and interpret imaging data Support other Clinical imaging research activities including PET tracer identification, development and study utilization External collaboration with Key Opinion Leaders in neuroimaging Interact with Imaging CROs Regulatory interactions regarding PET imaging in clinical development Contribute to design, editing, writing and review of protocols and technical imaging documents (e.g., imaging review charters) Work with data scientists and statisticians on analysis plans involving imaging endpoints Requirements PhD in relevant field plus at least 5 years of industry or academic experience Expert ability to plan, optimize and conduct PET imaging studies Good knowledge of PET instrumentation and acquisition protocols Ability to quantitate and interpret PET imaging data Ability to support other imaging research activities Experience communicating results to the project team members Experience preparing reports and giving presentations internally and externally Experience working collaboratively with team members, global unit members; key opinion leaders and CROs. Proactive, self-motivated and independent working style. Used to work in a multidisciplinary team and understand the needs and goals of the broader organization #LI-CC Eisai Salary Transparency Language: The annual base salary range for the Associate Director, Translational Imaging, Clinical Pharmacology & Translational Medicine is from :$169,400-$222,400 Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan & Eisai Inc. Long Term Incentive Plan. Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills. Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://careers.eisai.com/us/en/compensation-and-benefits. Certain other benefits may be available for this position, please discuss any questions with your recruiter. Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans. Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information: Right To Work E-Verify Participation At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn. All data that is entered should be in the correct case, please refrain from using all caps. For a better user experience, we recommend using the latest version of Chrome.